Advertisement

Topics

Biodel Inc. Company Profile

06:19 EDT 24th September 2017 | BioPortfolio

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes. Biodel's product candidates are developed using VIAdelTM technology, which reformulates existing FDA-approved peptide drugs. Biodel's new drug application for its most advanced product candidate, VIAject®, has been accepted for review by the FDA with a Prescription Drug User Fee Act action date of October 30, 2010. Earlier-stage product candidates include VIAtab™, a sublingual tablet formulation of insulin, a line of basal insulins, and a stabilized formulation of glucagon. For further information regarding Biodel, please visit the company's website at www.biodel.com.


News Articles [4 Associated News Articles listed on BioPortfolio]

Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012

DANBURY, Conn., May 7, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) will issue its second quarter fiscal year 2012 financial results on May 10, 2012.  Following the release of the company...

Biodel to Report Third Quarter Fiscal Year 2011 Financial Results on August 4, 2011

DANBURY, Conn., Aug. 1, 2011 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) will issue its third quarter fiscal year 2011 financial results on August 4, 2011.  Following the release of the company's ...

Biodel to Report First Quarter Fiscal Year 2012 Financial Results on February 8, 2012

DANBURY, Conn., Feb. 3, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) will issue its first quarter fiscal year 2012 financial results on February 8, 2012.  Following the release of...

Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas

DANBURY, Conn., July 26, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Biodel, Inc.

Biodel is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes. Biodel's produc...

Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes. Biodel's product candidates are develo...

More Information about "Biodel Inc." on BioPortfolio

We have published hundreds of Biodel Inc. news stories on BioPortfolio along with dozens of Biodel Inc. Clinical Trials and PubMed Articles about Biodel Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biodel Inc. Companies in our database. You can also find out about relevant Biodel Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record